The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Heart in Diabetes meeting brings together leaders from the fields of cardiology, endocrinology, nephrology and more to highlight the latest scientific data and clinical implications for practice.The ...

An analysis of pooled data from two large finerenone trials identified key risk factors for hyperkalemia in patients with CKD ...

Real-world data found people with schizophrenia treated with injectable extended-release risperidone (Uzedy) had lower rates ...

Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.

Akebia continues to publish important, clinically relevant data to further physicians’ understanding of Vafseo® ...

Patients gain no benefit from getting a donated kidney before their own kidneys deteriorate to the point that they require ...

PKD is a genetic disorder marked by kidney cysts and progressive damage. Discover the science, treatment guidelines, and ...

Consuming an abundance of protein can lead to digestive issues like constipation or diarrhea, while high-protein diets that ...

Rory Teeters loves gymnastics, especially practicing her skills on the balance bars and the beam. Rory, 7, has cystic fibrosis but with ongoing care from pediatric pulmonologist Dr. James Wallace, ...